The Floating Rate Strategies Fund (Institutional Class) returned -0.49 percent in Q1 2026 compared to the S&P UBS Leveraged ...
Pfizer Inc. (NYSE:PFE) ranks among the best low-risk investments in May 2026. On April 13, Guggenheim reaffirmed a Buy rating and a $36 price target for Pfizer Inc. (NYSE:PFE) as the firm revised its ...
Guggenheim trimmed its price target on Chipotle Mexican Grill (NYSE:CMG) to $35 from $36 on Friday, keeping a Neutral rating as margin pressure forces earnings estimate cuts. Analyst Gregory Francfort ...
24/7 Wall St. on MSN
Guggenheim trims Amgen price target to $340: Is the biotech giant losing its edge?
Quick Read Guggenheim trimmed its Amgen (AMGN) stock price target to $340 from $351 while maintaining Neutral, reflecting a ...
Guggenheim Investments’ President Dina DiLorenzo said the firm is working to launch a nontraded business development company, ...
Dina DiLorenzo, Guggenheim Investments president, joins 'Power Lunch' to discuss the market's recent resilience, credit ...
Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution schedule for each closed-end fund (collectively, the ...
Guggenheim Core Bond Fund (Institutional Class) returned -0.07% in the first quarter of 2026, compared with a -0.05% return ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results